🎉 Free to use until Sep 16, 2026 — try it out for our launch!
STOCKIQAISTOCKIQAI
עברית
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.15▼ 4.17%
TA-125₪4,032.47▲ 0.23%
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.15▼ 4.17%
TA-125₪4,032.47▲ 0.23%

MDLN

Medline Inc. Class A Common Stock

Health Care · ·

$34.51

▼ $2.16 (-5.9%)

Market Cap

—

Day Range

$34.47 - $36.50

52-Week Range

$32.82 - $50.88

Beta

—

Next Earnings

—

MDLN is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.

🏢 Similar Stocks in the Same Sector

AAPG

Ascentage Pharma Group International - American Depository

AARD

Aardvark Therapeutics, Inc.

ABCL

AbCellera Biologics Inc. - Common

-10.6% (1Y)

Investor Score
46/ 100D+
🟡 Moderate

This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer

📈27FTechnical
💰50C-Fundamental
🚀44DGrowth
💎50C-Valuation
📰68B-News
🏦58CQuality
⚠️42DRisk

Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%

🔍 Cross-Check

Overall Score

🟡 Mixed

Technical Trend

🔴 Bearish

Insiders

🔴 Bearish

✅ Why is the score relatively high?

  • 🟢 Operating margin is stable or improving over time
  • 🟢 CMF 20 days: 0.08

⚠️ What's concerning?

  • 🔴 ATR: 5.6% of price
  • 🔴 Net income growth: -0.9%
  • 🔴 Price is below the 50-day average
  • 🔴 MACD histogram is negative — falling momentum
  • 🔴 -23.8% over the last 3 months relative to the index

🚦 Quality & Risk Checks

🟢 Operating margin stability🔴 Daily volatility (ATR)

📰 News Trend

Based on real financial news (Finnhub)
🟡 Mixed

Everyone's writing about Medline Inc. Class A Common Stock. News trend score: 68. Reason: 5 of the last 13 articles are positive, versus 2 negative.

🟡 RBC Capital Maintains Outperform on Medline, Lowers Price Target to $46 — Benzinga🟡 Truist Securities Maintains Buy on Medline, Lowers Price Target to $47 — Benzinga🟡 Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39 — Benzinga

News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer

📈 Technical Analysis

Based on the last 158 trading days, calculated from real price data. Click an indicator for details and a chart.

🔴 Most indicators support a downtrend (1 bullish · 7 bearish · 2 neutral)

Conclusions

  • 🔴Price vs. SMA 50 — Price is below the 50-day average
  • 🔴MACD — MACD histogram is negative — falling momentum
  • 🔴RSI — RSI 41.9 — weak/negative bias
  • 🟡Stochastic — %K 27.5 — neutral range
  • 🟡ADX (trend strength) — ADX 13.8 — weak trend/choppy
  • 🔴Relative strength vs. S&P 500 — -23.8% over the last 3 months relative to the index
  • 🔴Bollinger Bands — Price is in the lower third of the Bollinger Bands (-4%B) — weakness (chance of a recovery)
  • 🔴ROC (rate of change) — ROC 12 days: -5.7%
  • 🔴Parabolic SAR — Price is below the SAR point — downtrend
  • 🟢CMF (money flow) — CMF 20 days: 0.08

Wyckoff Method Analysis

A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.

Markup

The stock is in a clear uptrend with no defined trading range in the period examined.

Low confidence

Evidence Behind This Read

  • 🟢Rising price trend — A 1.4% change over the last 50 days, with no defined trading range.
  • 🔴Divergence between price and cumulative money flow (A/D Line) — Price and the cumulative Accumulation/Distribution Line are moving in opposite directions — a classic Wyckoff sign that the move isn't backed by real money, and may be less stable than it looks.
  • 🟢Bar with selling-climax characteristics — On 2026-08-05: volume 4.7x the average and a spread 2.2x wider, with a close suggesting counter-absorption.

The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.

🎯 Trade Planning (M.A.E.E Framework)

Based on a mechanical trading method: market structure → value zone → ATR-based exit point. Not investment advice — a calculation tool only.

1️⃣ Market Structure

Not enough history to determine market structure (200-day average required).

2️⃣ Value Zone

🟡 Price far from value zone

The price is currently far from the 50-day average — the method recommends waiting for a "pullback" before entering, rather than chasing prices.

Not enough data (ATR / support / resistance) to calculate a suggested exit point.

💰 Financial Health

Profitability

Gross Margin

—

Operating Margin

—

Net Margin

—

EBITDA Margin

—

Efficiency

ROE

—

ROA

—

ROIC

—

EPS

—

Balance Sheet

Cash

—

Total Debt

—

Current Ratio

—

Debt/Equity

—

Conclusions

Not enough data to compute signals.

🚀 Growth

Revenue

Earnings per Share (EPS)

אין נתונים היסטוריים זמינים.

Net Income

Free Cash Flow (FCF)

Conclusions

  • 🔴Net income growth — Net income growth: -0.9%

💎 Fair Value (Valuation)

Not enough cash-flow data to calculate a DCF model for this stock.

Book Value per Share

—

Tangible Book Value per Share (Tangible NAV)

—

Conclusions

Not enough data to compute signals.

🕴️ Insider Trading

Real transactions by officers and insiders, as reported to the SEC on Form 4 — 1 purchases and 12 sales out of the last 25 filings.

NameTransaction TypeDateSharesChangePrice
Liberman Alexander M.Tax Withholding in Shares15.6.202611,031-872$36.61
GALANTI RICHARD AGrant/Award from Employer11.6.202616,392+5,387—
Bluedorn Todd MGrant/Award from Employer11.6.202615,732+5,387—
Sweet Thomas WGrant/Award from Employer11.6.20265,387+5,387—
CORCORAN JESSI LOpen Market Purchase5.6.20265,000+5,000$34.15
SCHWARZMAN STEPHEN AOpen Market Sale28.5.202689,537,913-19,712,326$36.54
SCHWARZMAN STEPHEN AOpen Market Sale28.5.202610,185-9,858,774$36.54
SCHWARZMAN STEPHEN AOpen Market Sale28.5.202610,250,904-2,256,800$36.54
SCHWARZMAN STEPHEN AOpen Market Sale28.5.20261,539-1,489,924$36.54
SCHWARZMAN STEPHEN AOther Transaction28.5.20261,990,467-438,214—
HEALY PATRICK JOther Transaction28.5.20261,387,921+179,762—
HEALY PATRICK JOther Transaction28.5.2026172,383+22,344—
HFCP X (Parallel-A), L.P.Open Market Sale28.5.2026228,840-17,947,337$36.54
HFCP X (Parallel-A), L.P.Open Market Sale28.5.20263,422,699-753,528$36.54
HFCP X (Parallel-A), L.P.Open Market Sale28.5.202662,591,526-11,904,646$36.54
HFCP X (Parallel-A), L.P.Open Market Sale28.5.20266,519,062-1,262,726$36.54
HFCP X (Parallel-A), L.P.Other Transaction28.5.202619,310-209,530—
HFCP X (Parallel-A), L.P.Other Transaction28.5.202661,054,619-1,536,907—
HFCP X (Parallel-A), L.P.Other Transaction28.5.20266,377,698-141,364—
BX Mozart ML-2 Holdco L.P.Open Market Sale28.5.202689,537,913-19,712,326$36.54
BX Mozart ML-2 Holdco L.P.Open Market Sale28.5.202610,185-9,858,774$36.54
BX Mozart ML-2 Holdco L.P.Open Market Sale28.5.202610,250,904-2,256,800$36.54
BX Mozart ML-2 Holdco L.P.Open Market Sale28.5.20261,539-1,489,924$36.54
BX Mozart ML-2 Holdco L.P.Other Transaction28.5.20261,990,467-438,214—
SCHWARZMAN STEPHEN AConversion of Derivative Security21.5.20269,868,959+9,858,774—

📉 Short Interest

Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.

Monthly Trend — Open Short Interest

↓-18.9%

29,452,298 shares short as of 2026-07-15 · vs. 36,298,239 on 2026-06-30

Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.

Weekly Trend — Daily Short-Sale Activity

↓-20.7%

45.5% of trading volume this week was short selling, vs. 57.5% the prior week

Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.

📰 News & Sentiment

Sentiment based on basic keywords (not AI) — 5 positive, 6 neutral, 2 negative out of the last 13 articles.